Business Description
TC BioPharm (Holdings) PLC
ISIN : US87807D4007
Description
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.57 | |||||
Equity-to-Asset | 0.15 | |||||
Debt-to-Equity | 1.6 | |||||
Debt-to-EBITDA | 1.94 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 51.6 | |||||
3-Year EPS without NRI Growth Rate | 39.5 | |||||
3-Year FCF Growth Rate | 34.5 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 42.64 | |||||
9-Day RSI | 41.87 | |||||
14-Day RSI | 41.68 | |||||
6-1 Month Momentum % | -62.41 | |||||
12-1 Month Momentum % | -90.64 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.88 | |||||
Quick Ratio | 0.88 | |||||
Cash Ratio | 0.21 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -232.4 | |||||
Shareholder Yield % | 52.7 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -121.98 | |||||
ROA % | -28.81 | |||||
ROIC % | -145.08 | |||||
ROC (Joel Greenblatt) % | 19.74 | |||||
ROCE % | 14.78 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 1.02 | |||||
PB Ratio | 2.38 | |||||
Price-to-Tangible-Book | 5.68 | |||||
EV-to-EBIT | 9.3 | |||||
EV-to-EBITDA | 5.29 | |||||
EV-to-Forward-Revenue | 0.01 | |||||
EV-to-FCF | -0.77 | |||||
Earnings Yield (Greenblatt) % | 10.75 | |||||
FCF Yield % | -153.64 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
TC BioPharm (Holdings) PLC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | 0.922 | ||
Beta | 0 | ||
Volatility % | 88.74 | ||
14-Day RSI | 41.68 | ||
14-Day ATR (€) | 0.068935 | ||
20-Day SMA (€) | 1.0015 | ||
12-1 Month Momentum % | -90.64 | ||
52-Week Range (€) | 0.805 - 15.1 | ||
Shares Outstanding (Mil) | 4.95 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
TC BioPharm (Holdings) PLC Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
TC BioPharm (Holdings) PLC Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
TC BioPharm (Holdings) PLC Frequently Asked Questions
What is TC BioPharm (Holdings) PLC(STU:T0U)'s stock price today?
When is next earnings date of TC BioPharm (Holdings) PLC(STU:T0U)?
Does TC BioPharm (Holdings) PLC(STU:T0U) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |